PDE6B and retinitis pigmentosa 1: A clinical trial on the safety and efficacy of gene therapy in human patients with RP caused by bi-allelic mutations in the PDE6B gene is currently ongoing (ClinicalTrials.gov Identifier: NCT03328130).